(1) When tested in vitro in CD34+ cells from SCD patients, the target site editing efficiency with PE5 was relatively low, 5%, compared with ∼20% in CD46/Townes lineage-negative (Lin−) cells, a bone marrow (BM) cell fraction enriched for HSCs.5 Here, CD34 is linked to Schnyder corneal dystrophy.